Regeneron Pharmaceuticals Inc. buy BMO Capital Markets
Start price
02.06.25
/
50%
€427.60
Target price
02.06.26
€527.70
Performance (%)
48.60%
Price
17:42
€632.70
Summary
This prediction is currently active. With a performance of 48.60% the BUY prediction by BMO_Capital_Markets is a big success. Dividends of €2.70 are taken into consideration when calculating the performance. This prediction currently runs until 02.06.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | -3.506% | -3.506% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at BMO Capital Markets from $800.00 to $600.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€625.20
04.12.25
04.12.25
€728.79
04.12.26
04.12.26
1.35%
17:42
17:42
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€494.10
04.08.25
04.08.25
€552.90
04.08.26
04.08.26
28.60%
17:42
17:42
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€515.60
30.04.25
30.04.25
€703.60
30.04.26
30.04.26
23.41%
17:42
17:42
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€681.40
04.02.25
04.02.25
€869.77
04.02.26
04.02.26
-4.08%
05.02.26
05.02.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,096.8
01.11.25
01.11.25
-27.09%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€939.20
24.09.24
24.09.24
€1,165.3
24.09.25
24.09.25
-47.87%
25.09.25
25.09.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€858.00
05.02.24
05.02.24
€1,006.8
05.02.25
05.02.25
-19.14%
06.02.25
06.02.25